Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer’s Disease

Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer’s Disease

Dementia with Lewy Bodies (DLB) is a common form of cognitive neurodegenerative disease. Only one third of patients are correctly diagnosed due to the clinical similarity mainly with Alzheimer’s disease (AD). In this review, we evaluate the interest of different biomarkers: cerebrospinal fluid (CSF)...

Full description

Bibliographic Details
Main Authors:	Olivier Bousiges, Frédéric Blanc
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Series:	International Journal of Molecular Sciences
Subjects:	dementia with lewy bodies Alzheimer’s disease cerebro-spinal fluid biomarkers α-synuclein brain MRI
Online Access:	https://www.mdpi.com/1422-0067/23/12/6371

Similar Items

Dementia with Lewy bodies: an update and outlook
by: Tiago Fleming Outeiro, et al.
Published: (2019-01-01)

Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions
by: Masahito Yamada, et al.
Published: (2020-01-01)

Synuclein Motor Dysfunction Composite Scale for the Discrimination of Dementia With Lewy Bodies From Alzheimer’s Disease
by: Ying-Tsung Chen, et al.
Published: (2022-05-01)

Inflammation in dementia with Lewy bodies
by: Jay Amin, et al.
Published: (2022-06-01)

Clinical biomarkers for Lewy body diseases
by: Mai M. Abdelmoaty, et al.
Published: (2023-11-01)

Long-term cognitive outcome of Alzheimer’s disease and dementia with Lewy bodies: dual disease is worse
by: Frédéric Blanc, et al.
Published: (2017-06-01)

Frailty in Older Adults with Mild Dementia: Dementia with Lewy Bodies and Alzheimer’s Disease
by: Miguel Germán Borda, et al.
Published: (2019-04-01)

Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies
by: Christopher Hatton, et al.
Published: (2020-07-01)

Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies
by: Marta Barrachina, et al.
Published: (2006-05-01)

Investigation of Inflammation in Lewy Body Dementia: A Systematic Scoping Review
by: Paula M. Loveland, et al.
Published: (2023-07-01)

Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer’s Disease in Clinical Practice
by: Matthieu Lilamand, et al.
Published: (2022-11-01)

Parkinson’s Disease Dementia and Dementia with Lewy Bodies Have Similar Neuropsychological Profiles
by: Georgina M. Aldridge, et al.
Published: (2018-03-01)

Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies
by: Aikaterini Foska, et al.
Published: (2022-04-01)

Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies
by: Fernando L. Pagan, et al.
Published: (2022-01-01)

Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers
by: Tomohiro Umeda, et al.
Published: (2021-08-01)

Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
by: Inger van Steenoven, et al.
Published: (2020-06-01)

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
by: David J. Koss, et al.
Published: (2022-07-01)

Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies
by: Connor Bargar, et al.
Published: (2021-04-01)

Gender differences in Parkinson's disease with dementia and dementia with Lewy bodies
by: Lidadi L. Agbomi, et al.
Published: (2022-12-01)

Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression
by: Zachary A. Sorrentino, et al.
Published: (2019-09-01)

Autophagy Markers Are Altered in Alzheimer’s Disease, Dementia with Lewy Bodies and Frontotemporal Dementia
by: Antonio Longobardi, et al.
Published: (2024-01-01)

The gesture imitation test in dementia with Lewy bodies and Alzheimer's disease dementia
by: Xudong Li, et al.
Published: (2022-07-01)

Clinico‐pathological comparison of patients with autopsy‐confirmed Alzheimer's disease, dementia with Lewy bodies, and mixed pathology
by: Atri Chatterjee, et al.
Published: (2021-01-01)

Differentiation Between Dementia With Lewy Bodies And Alzheimer’s Disease Using Voxel-Based Morphometry Of Structural MRI: A Multicenter Study
by: Matsuda H, et al.
Published: (2019-09-01)

Relationship between Dementia Severity and Behavioral and Psychological Symptoms of Dementia in Dementia with Lewy Bodies and Alzheimer's Disease Patients
by: Mamoru Hashimoto, et al.
Published: (2015-06-01)

Neuropathological evidence of body-first vs. brain-first Lewy body disease
by: Per Borghammer, et al.
Published: (2021-12-01)

Norovirus Intestinal Infection and Lewy Body Disease in an Older Patient with Acute Cognitive Impairment
by: Manuel Moreno-Valladares, et al.
Published: (2022-07-01)

Lateralized ante mortem and post mortem pathology in a case of Lewy body disease with corticobasal syndrome
by: David G. Coughlin, et al.
Published: (2022-01-01)

Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
by: Ming-Chyi Pai, et al.
Published: (2021-10-01)

Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies
by: Joshua T. Geiger, et al.
Published: (2016-10-01)

Dementia with lewy bodies - diagnosis and treatment
by: IG McKeith
Published: (2003-03-01)

Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
by: M. van de Beek, et al.
Published: (2020-04-01)

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
by: Davide Chiasserini, et al.
Published: (2017-07-01)

α-Synuclein Strains and Their Relevance to Parkinson’s Disease, Multiple System Atrophy, and Dementia with Lewy Bodies
by: Noah J. Graves, et al.
Published: (2023-07-01)

Reorganization of rich clubs in functional brain networks of dementia with Lewy bodies and Alzheimer’s disease
by: Wen-ying Ma, et al.
Published: (2022-01-01)

Plasma metabolites distinguish dementia with Lewy bodies from Alzheimer’s disease: a cross-sectional metabolomic analysis
by: Xiaobei Pan, et al.
Published: (2024-01-01)

A Longitudinal Study of Neurocognition in Dementia with Lewy Bodies Compared to Alzheimer’s Disease
by: Monica H. Breitve, et al.
Published: (2018-03-01)

Sex ratio in dementia with Lewy bodies balanced between Alzheimer’s disease and Parkinson’s disease dementia: a cross-sectional study
by: A. Mouton, et al.
Published: (2018-09-01)

Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data
by: Carla Abdelnour, et al.
Published: (2022-01-01)

Role of Alterations in Protein Kinase p38γ in the Pathogenesis of the Synaptic Pathology in Dementia With Lewy Bodies and α-Synuclein Transgenic Models
by: Michiyo Iba, et al.
Published: (2020-03-01)